Lupin Mexiletine Hydrochloride gets Orphan Drug Designation from USFDA Ruchika Sharma9 Jun 2020 11:04 AM ISTMexiletine reduces myotonia symptoms, resulting in a significant improvement in patient quality-of-life and other functional outcomes
Lupin, Mylan get European nod to market Nepexto for treating arthritis, psoriasis Ruchika Sharma5 Jun 2020 12:08 PM ISTMumbai: Lupin Limited and Mylan N.V. have announced that the European Commission (EC) has granted marketing authorization for Nepexto®, a biosimilar...
Lupin signs agreement with Macure Pharma, others to commercialise NaMuscla in Europe Ruchika Sharma4 Jun 2020 12:28 PM ISTLupin will continue the commercialization of NaMuscla® in Germany and the UK and will launch the product in Austria and France later this year
Lupin gets USFDA approval for Meloxicam to treat osteoarthritis pain Ruchika Sharma3 Jun 2020 10:45 AM ISTMeloxicam Capsules, 5 mg and 10 mg, are indicated for the management of osteoarthritis (OA) pain
Lupin Net Profit Rises 35pc to Rs 390 crore in Q4 Farhat Nasim2 Jun 2020 9:00 AM ISTLupin had posted a net profit of Rs 289.56 crore for the corresponding period of the previous fiscal.
Lupin gets USFDA nod for Trientine Hydrochloride Capsules Ruchika Sharma23 May 2020 12:15 PM ISTTrientine Hydrochloride Capsules USP, 250 mg, are indicated in the treatment of patients with Wilson's disease who are intolerant of penicillamine
Lupin Launches Generic Apriso in US Ruchika Sharma21 May 2020 11:00 AM ISTMumbai, Baltimore: Drug Maker Lupin Limited has announced the launch of an authorized generic version of Bausch Health's Apriso® (Mesalamine...
Lupin receives USFDA EIR for Vizag API Facility Ruchika Sharma14 May 2020 4:19 PM ISTMumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration...
Lupin Pithampur plant Completes Successful UK MHRA Inspection Ruchika Sharma9 May 2020 1:53 PM ISTMumbai: Lupin Limited has announced the successful close out of the inspection carried out by the Medicines and Healthcare products Regulatory...
Lupin Launches Jan Kovid Helpline in Mumbai Ruchika Sharma7 May 2020 12:45 PM ISTThe service is available in Marathi, Hindi, Gujarati and English, and will be operational all days from 8 am – 8 pm
Lupin Announces Positive Topline Results From its Phase 3 Study of Single-Dose Solosec® (secnidazole) in Trichomoniasis Ruchika Sharma4 May 2020 5:54 PM ISTSolosec® is approved by the FDA to treat bacterial vaginosis (BV) in adult women.
Lupin gets USFDA EIR for Pithampur Unit-1 facility Ruchika Sharma1 May 2020 11:00 AM ISTMumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration...
